logo
welcome
TipRanks

TipRanks

Vaxart project agreement change ups funding for oral COVID vaccine candidate

TipRanks
Summary
Nutrition label

83% Informative

Vaxart (VXRT) received funding for a Phase 2b comparative study evaluating the Company ’s oral pill XBB COVID-19 vaccine candidate against an mRNA vaccine comparator approved by the U.S. Food and Drug Administration .

The Modification increased the total estimated ceiling for the funding to the Company to approximately $460.7M , representing an increase of approximately $4.6M.

VR Score

75

Informative language

70

Neutral language

62

Article tone

formal

Language

English

Language complexity

95

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

Affiliate links

no affiliate links